ScholarIQanswers from OpenAlex

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?

PaperCitations, authors & open-access status

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? is a paper indexed in ScholarIQ from OpenAlex.

How many citations does When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? have?

ScholarIQcitation count

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? has 13 citations in the OpenAlex counts ScholarIQ stores.

When was When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? published?

ScholarIQyear

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? has 2023 year in the ScholarIQ index.

What is the open-access status of When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients??

ScholarIQoa status

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? has hybrid oa status in the ScholarIQ index.

What is the DOI of When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients??

ScholarIQdoi

The DOI for When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? is on the source record.

What is the PMID of When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients??

ScholarIQpmid

The PMID for When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? is on the source record.

What is the OpenAlex record for When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients??

ScholarIQopenalex

The OpenAlex for When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial